CN1293882C - 具有降低血清胆固醇作用的复方植物甾醇及其制备工艺 - Google Patents
具有降低血清胆固醇作用的复方植物甾醇及其制备工艺 Download PDFInfo
- Publication number
- CN1293882C CN1293882C CNB031180205A CN03118020A CN1293882C CN 1293882 C CN1293882 C CN 1293882C CN B031180205 A CNB031180205 A CN B031180205A CN 03118020 A CN03118020 A CN 03118020A CN 1293882 C CN1293882 C CN 1293882C
- Authority
- CN
- China
- Prior art keywords
- oil
- plant sterol
- plant
- cholesterol
- gallbladder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 22
- 210000002966 serum Anatomy 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title description 4
- 235000002378 plant sterols Nutrition 0.000 claims abstract description 90
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 73
- 239000003921 oil Substances 0.000 claims abstract description 53
- 235000019198 oils Nutrition 0.000 claims abstract description 53
- 230000000694 effects Effects 0.000 claims abstract description 31
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims abstract description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 12
- 235000011615 Pinus koraiensis Nutrition 0.000 claims abstract description 11
- 240000007263 Pinus koraiensis Species 0.000 claims abstract description 11
- 235000021323 fish oil Nutrition 0.000 claims abstract description 9
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 238000002844 melting Methods 0.000 claims abstract description 3
- 230000008018 melting Effects 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 12
- 235000013355 food flavoring agent Nutrition 0.000 claims description 12
- 235000021324 borage oil Nutrition 0.000 claims description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000003026 cod liver oil Substances 0.000 claims description 7
- 235000012716 cod liver oil Nutrition 0.000 claims description 7
- 239000007910 chewable tablet Substances 0.000 claims description 4
- 229940068682 chewable tablet Drugs 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 230000005496 eutectics Effects 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 abstract description 49
- 239000000203 mixture Substances 0.000 abstract description 25
- 239000003995 emulsifying agent Substances 0.000 abstract description 14
- -1 sucrose fatty acid ester Chemical class 0.000 abstract description 14
- 229930006000 Sucrose Natural products 0.000 abstract description 13
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 13
- 229930195729 fatty acid Natural products 0.000 abstract description 13
- 239000000194 fatty acid Substances 0.000 abstract description 13
- 239000005720 sucrose Substances 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 5
- KXFNZUHMPODMRZ-UHFFFAOYSA-N 2-hydroxypropanoic acid;octadecanoic acid Chemical compound CC(O)C(O)=O.CCCCCCCCCCCCCCCCCC(O)=O KXFNZUHMPODMRZ-UHFFFAOYSA-N 0.000 abstract description 4
- 241000251468 Actinopterygii Species 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract 2
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 abstract 1
- 240000008415 Lactuca sativa Species 0.000 abstract 1
- 235000003228 Lactuca sativa Nutrition 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000004519 grease Substances 0.000 abstract 1
- 235000021388 linseed oil Nutrition 0.000 abstract 1
- 239000000944 linseed oil Substances 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 description 44
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
- 235000012000 cholesterol Nutrition 0.000 description 26
- 150000002632 lipids Chemical class 0.000 description 20
- 235000013305 food Nutrition 0.000 description 15
- 235000014655 lactic acid Nutrition 0.000 description 15
- 239000004310 lactic acid Substances 0.000 description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 13
- 239000011575 calcium Substances 0.000 description 13
- 229910052791 calcium Inorganic materials 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 235000011837 pasties Nutrition 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000001816 cooling Methods 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 9
- 235000012054 meals Nutrition 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000001906 cholesterol absorption Effects 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229940068065 phytosterols Drugs 0.000 description 6
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 4
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 4
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 4
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 4
- 235000000431 campesterol Nutrition 0.000 description 4
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 229950005143 sitosterol Drugs 0.000 description 4
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 4
- 235000016831 stigmasterol Nutrition 0.000 description 4
- 229940032091 stigmasterol Drugs 0.000 description 4
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 4
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 208000019553 vascular disease Diseases 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 239000003264 margarine Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- VGSSUFQMXBFFTM-UHFFFAOYSA-N (24R)-24-ethyl-5alpha-cholestane-3beta,5,6beta-triol Natural products C1C(O)C2(O)CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 VGSSUFQMXBFFTM-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N 2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 235000010830 Prunus insititia Nutrition 0.000 description 1
- 244000039376 Prunus insititia Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004903 negative regulation of intestinal cholesterol absorption Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 238000011680 zucker rat Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031180205A CN1293882C (zh) | 2003-01-15 | 2003-01-15 | 具有降低血清胆固醇作用的复方植物甾醇及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031180205A CN1293882C (zh) | 2003-01-15 | 2003-01-15 | 具有降低血清胆固醇作用的复方植物甾醇及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1454598A CN1454598A (zh) | 2003-11-12 |
CN1293882C true CN1293882C (zh) | 2007-01-10 |
Family
ID=29260222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031180205A Expired - Fee Related CN1293882C (zh) | 2003-01-15 | 2003-01-15 | 具有降低血清胆固醇作用的复方植物甾醇及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1293882C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102056499B (zh) * | 2007-10-16 | 2014-12-31 | 阿克特基因组学有限公司 | 用于调节脂质代谢的组合物 |
CN102318686B (zh) * | 2011-06-01 | 2012-12-19 | 黑龙江省大豆技术开发研究中心 | 一种制备含有植物甾醇酯的功能性保健油脂的方法 |
CN104187627B (zh) * | 2014-08-11 | 2016-03-02 | 无限极(中国)有限公司 | 一种降血脂组合物及其在制备具有降血脂功能的保健食品中的应用 |
CN104970360A (zh) * | 2015-06-19 | 2015-10-14 | 贵州神奇药物研究院 | 降血脂的保健食品及其制备方法 |
CN108124981A (zh) * | 2018-01-30 | 2018-06-08 | 湖南嘉耘油脂有限公司 | 一种强化植物甾醇酯和γ-亚麻酸的食用油及制备方法 |
CN109674053A (zh) * | 2019-01-09 | 2019-04-26 | 江南大学 | 一种减肥降脂植物甾醇纳米乳液及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1258199A (zh) * | 1998-03-24 | 2000-06-28 | 花王株式会社 | 含有植物甾醇的油脂组合物 |
US6113972A (en) * | 1998-12-03 | 2000-09-05 | Monsanto Co. | Phytosterol protein complex |
WO2001032031A2 (en) * | 1999-11-04 | 2001-05-10 | Monsanto Technology Llc | Cholesterol reducing sterol compositions, preparation and method of use |
-
2003
- 2003-01-15 CN CNB031180205A patent/CN1293882C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1258199A (zh) * | 1998-03-24 | 2000-06-28 | 花王株式会社 | 含有植物甾醇的油脂组合物 |
US6113972A (en) * | 1998-12-03 | 2000-09-05 | Monsanto Co. | Phytosterol protein complex |
WO2001032031A2 (en) * | 1999-11-04 | 2001-05-10 | Monsanto Technology Llc | Cholesterol reducing sterol compositions, preparation and method of use |
Also Published As
Publication number | Publication date |
---|---|
CN1454598A (zh) | 2003-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1237071C (zh) | 植物甾醇或植物甾烷醇的抗坏血酸衍生物及其组合物、食品和用途 | |
CN1263453C (zh) | 基于微粉化孕酮的药物组合物及其制造方法和用途 | |
CN1468066A (zh) | 分散用于饮料的植物甾醇的方法以及在分散饮料中颗粒大小为纳米级的植物甾醇分散的饮料 | |
CN1414834A (zh) | 包含食用油或脂肪和基本上溶于其中的植物甾醇和/或植物甾烷醇的组合物 | |
CN1057768C (zh) | 由木浆皂得到的甾醇组合物 | |
WO2000015201A2 (en) | Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other disorders | |
CN1370179A (zh) | 用于治疗或预防心血管疾病的植物甾醇和/或植物甾烷醇的芳族和杂环衍生物 | |
CN1293882C (zh) | 具有降低血清胆固醇作用的复方植物甾醇及其制备工艺 | |
WO2003090547A1 (en) | A composition comprising waxy acids for effecting serum cholesterol levels | |
CN1297216C (zh) | 植物甾醇与乳化剂的混合粉末及其制备方法 | |
CN1829499A (zh) | 稳定并控制传递(-)-羟基柠檬酸的方法和组合物 | |
WO2001066560A2 (en) | Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders | |
US20070141123A1 (en) | Emulsions comprising non-esterified phytosterols in the aqueous phase | |
CN1684971A (zh) | 包括甾醇和 /或甾烷醇的新结构和组合物 ,以及特殊类别的抗炎药和其治疗或预防心血管病及其潜伏状况的用途 ,包括治疗高脂血症和其它以炎症为部分病因或症状的病症 | |
CN1034574C (zh) | 5-氧取代的(rs)-2-(2,3-二氢-4,6,7-三甲基苯并呋喃基)乙酸衍生物的制备方法 | |
CN1822830A (zh) | 含有氮杂环丁烷衍生物的乳化系统 | |
CN101057674A (zh) | 一种用于防治糖尿病的组合物 | |
CN1774444A (zh) | 与抗坏血酸偶合的雄甾烷和雄甾烯的新衍生物及其在治疗或预防多种病症、疾病和机能障碍中的用途 | |
CN1499965A (zh) | 骨代谢改善剂 | |
CN1225175C (zh) | 降糖牛奶及其制造方法 | |
CN1681514A (zh) | 一种治疗糖尿病,包括与糖尿病有关的疾病和糖尿病并发症的方法 | |
CN100334958C (zh) | 含有未酯化甾醇类的乳制品 | |
CN1299585C (zh) | 一种预防和改善心脑血管疾病的奶粉和其制造方法 | |
CN1965862A (zh) | 一种口服复方降脂药 | |
CN1742783A (zh) | 一种扶正益气天然药物制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGSHA CITY SDANO BIOISYSTECH CO., LTD. Free format text: FORMER OWNER: LI ANGUO Effective date: 20091023 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091023 Address after: Hunan province Changsha Furong District Road No. 98 hung in Longping hi-tech Incubator Building No. 1 building 501 room Patentee after: Changsha ideal Biotechnology Co., Ltd. Address before: Room 3, building 2, 502 worker peasant new village, Changsha, Hunan Patentee before: Li Anguo |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070110 Termination date: 20210115 |